Get the Stockscreener App
5.32
1.92%
+0.10
Editas Medicine Inc Stock (EDIT) Forecast
The Editas Medicine Inc (EDIT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.66, representing a +194.34% increase from the current price of $5.32. The highest analyst price target is $18.06, and the lowest is $13.26.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EDIT Price Target
Average 17.42
(+227.43% Upside)
Is Editas Medicine Inc (EDIT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 26.03 | Buy |
| STOCH(9,6) | 13.68 | Buy |
| STOCHRSI(14) | 19.45 | Buy |
| MACD(12,26) | -0.642 | Sell |
| ADX(14) | 34.91 | Sell |
| William %R | -89.06 | Buy |
| CCI(14) | -87.99 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.553
Sell
|
5.6217
Sell
|
| MA20 |
6.1613
Sell
|
6.1145
Sell
|
| MA50 |
7.5345
Sell
|
7.0548
Sell
|
| MA100 |
8.3095
Sell
|
7.7097
Sell
|
| MA200 |
8.3161
Sell
|
8.1649
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EDIT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on EDIT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 26.03 indicates that EDIT is oversold. This indicates that EDIT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 13.68 indicates that EDIT is oversold. This indicates that EDIT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.45 indicates that EDIT is oversold. This suggests that EDIT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.91 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -87.99 indicates that EDIT is still oversold but not to an extreme extent.
Long-term EDIT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Editas Medicine Inc financial reports and earnings history, Editas Medicine Inc (EDIT) stock could reach $8.0503 by 2030, $9.5496 by 2040 and $16.87 by 2050. See the projected annual prices until 2050 of the Editas Medicine Inc stock below:
- Editas Medicine Inc (EDIT) is expected to reach an average price of $4.4878 in 2035, with a high prediction of $3.7778 and a low estimate of $3.9635. This indicates an $-15.64% rise from the last recorded price of $5.32.
- Editas Medicine Inc (EDIT) stock is projected to chart a bullish course in 2040, with an average price target of $10.46, representing an $96.61% surge from its current level. The forecast ranges from a conservative $9.1411 to a sky-high $9.5496.
- Our analysts predict Editas Medicine Inc (EDIT) to jump 117.86% by 2045, soaring from $9.3516 to an average price of $11.59, potentially reaching $10.80. While $9.3516 is the low estimate, the potential upside is significant.
- Editas Medicine Inc (EDIT) stock is expected to climb by 2050, reaching an average of $17.13, a $221.98% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.87 and $15.31, respectively, highlighting the market's uncertainty.
Editas Medicine Inc Stock (EDIT) Year by Year Forecast
Editas Medicine Inc Stock (EDIT) Price Forecast for 2024
Our forecast for EDIT stock price in 2024 now indicates an average price target of $13.41 with a high forecast of $18.06 and a low forecast of $8.761. The average prediction reflects an increase of +152.08% from the last recorded price of $5.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $14.79 | $13.26 | $18.06 | +177.97% |
| June, 2024 | $10.68 | $10.60 | $16.02 | +100.83% |
| July, 2024 | $14.25 | $10.34 | $15.36 | +167.79% |
| August, 2024 | $15.69 | $13.64 | $17.24 | +194.87% |
| September, 2024 | $14.97 | $12.82 | $16.48 | +181.30% |
| October, 2024 | $12.74 | $12.60 | $17.14 | +139.39% |
| November, 2024 | $10.28 | $9.7385 | $13.68 | +93.16% |
| December, 2024 | $13.29 | $10.16 | $14.07 | +149.89% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2025
Editas Medicine Inc Stock (EDIT) is expected to reach an average price of $18.08 in 2025, with a high prediction of $31.25 and a low estimate of $4.8992. This indicates an +239.79% rise from the last recorded price of $5.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $20.38 | $13.08 | $22.39 | +283.17% |
| February, 2025 | $19.76 | $19.45 | $23.48 | +271.34% |
| March, 2025 | $18.91 | $16.69 | $25.10 | +255.51% |
| April, 2025 | $14.72 | $10.89 | $19.00 | +176.77% |
| May, 2025 | $10.29 | $4.8992 | $14.17 | +93.50% |
| June, 2025 | $14.13 | $9.142 | $17.52 | +165.65% |
| July, 2025 | $21.17 | $12.44 | $21.21 | +297.99% |
| August, 2025 | $23.44 | $16.12 | $24.70 | +340.67% |
| September, 2025 | $23.47 | $19.60 | $27.95 | +341.20% |
| October, 2025 | $26.23 | $20.13 | $31.25 | +393.09% |
| November, 2025 | $21.85 | $19.89 | $29.55 | +310.77% |
| December, 2025 | $18.54 | $18.48 | $25.50 | +248.51% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2026
The predicted value for Editas Medicine Inc (EDIT) in 2026 is set at an average of $55.18. Estimates vary from a peak of $91.69 to a trough of $18.68, indicating an +937.26% surge from the present price of $5.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $22.48 | $18.94 | $26.57 | +322.58% |
| February, 2026 | $22.95 | $18.68 | $24.46 | +331.43% |
| March, 2026 | $75.23 | $21.47 | $88.15 | +1,314% |
| April, 2026 | $57.53 | $54.27 | $91.69 | +981.40% |
| May, 2026 | $48.33 | $44.59 | $62.22 | +808.48% |
| June, 2026 | $32.41 | $27.98 | $48.11 | +509.19% |
| July, 2026 | $26.67 | $25.58 | $37.55 | +401.31% |
| August, 2026 | $25.30 | $21.42 | $31.55 | +375.52% |
| September, 2026 | $28.04 | $24.49 | $31.04 | +427.04% |
| October, 2026 | $40.80 | $27.89 | $52.21 | +666.90% |
| November, 2026 | $54.98 | $29.91 | $58.71 | +933.40% |
| December, 2026 | $60.64 | $49.93 | $65.41 | +1,040% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Editas Medicine Inc (EDIT) is $33.86, with a high forecast of $64.91 and a low forecast of $2.8059. This indicates an +536.38% increase from the last price of $5.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $33.51 | $32.07 | $64.91 | +529.85% |
| February, 2027 | $30.26 | $26.87 | $33.60 | +468.77% |
| March, 2027 | $24.99 | $24.54 | $34.69 | +369.67% |
| April, 2027 | $22.57 | $19.51 | $26.49 | +324.19% |
| May, 2027 | $10.93 | $10.89 | $23.58 | +105.36% |
| June, 2027 | $8.9758 | $8.8158 | $12.99 | +68.72% |
| July, 2027 | $8.9763 | $6.131 | $12.22 | +68.73% |
| August, 2027 | $13.22 | $6.8215 | $13.68 | +148.58% |
| September, 2027 | $6.3149 | $5.9749 | $14.62 | +18.70% |
| October, 2027 | $4.8254 | $2.8202 | $9.0326 | -9.30% |
| November, 2027 | $6.7036 | $2.8059 | $7.1763 | +26.01% |
| December, 2027 | $8.2941 | $4.8312 | $9.5641 | +55.90% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2028
In 2028, Editas Medicine Inc (EDIT) is projected to reach an average price of $6.8771, with a high projection of $13.34 and a low estimate of $0.4097. This indicates an +29.27% rise from the last price of $5.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.1122 | $8.0522 | $13.34 | +52.49% |
| February, 2028 | $9.2927 | $7.5451 | $10.02 | +74.68% |
| March, 2028 | $5.5332 | $5.2532 | $9.6404 | +4.01% |
| April, 2028 | $6.1537 | $4.6061 | $6.7685 | +15.67% |
| May, 2028 | $4.2919 | $3.2666 | $7.8514 | -19.33% |
| June, 2028 | $2.6024 | $2.4524 | $4.3895 | -51.08% |
| July, 2028 | $3.4205 | $1.5203 | $3.6205 | -35.70% |
| August, 2028 | $4.071 | $2.8882 | $5.8133 | -23.48% |
| September, 2028 | $1.8215 | $1.4715 | $3.8887 | -65.76% |
| October, 2028 | $1.6697 | $0.4097 | $2.7442 | -68.62% |
| November, 2028 | $3.7302 | $1.6523 | $4.8602 | -29.88% |
| December, 2028 | $3.8907 | $2.9831 | $4.6778 | -26.87% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2029
The 2029 price forecast for Editas Medicine Inc Stock (EDIT) is $3.9424 on average, with a high prediction of $7.7546 and a low estimate of $0.1303. This represents an -25.89% decrease from the previous price of $5.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.7188 | $1.9836 | $6.1659 | -48.89% |
| February, 2029 | $3.1593 | $2.7265 | $3.5165 | -40.61% |
| March, 2029 | $3.2198 | $2.6646 | $3.917 | -39.48% |
| April, 2029 | $2.388 | $2.248 | $3.9604 | -55.11% |
| May, 2029 | $0.8985 | $0.8885 | $3.1356 | -83.11% |
| June, 2029 | $2.349 | $0.706 | $3.739 | -55.85% |
| July, 2029 | $5.2771 | $1.8466 | $6.4571 | -0.81% |
| August, 2029 | $2.0253 | $0.1303 | $6.2148 | -61.93% |
| September, 2029 | $0.8763 | $0.9805 | $7.531 | -83.53% |
| October, 2029 | $0.5375 | $0.6185 | $2.102 | -89.90% |
| November, 2029 | $4.0336 | $0.2422 | $4.4983 | -24.18% |
| December, 2029 | $5.4998 | $2.3041 | $7.7546 | +3.38% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2030
Editas Medicine Inc Stock (EDIT) is expected to reach an average price of $8.009 in 2030, with a high forecast of $15.83 and a low forecast of $0.187. This signifies an +50.54% surge from the last price of $5.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.2609 | $3.2656 | $8.0503 | -19.91% |
| February, 2030 | $2.6419 | $0.4319 | $3.9511 | -50.34% |
| March, 2030 | $4.4129 | $1.3071 | $5.5229 | -17.05% |
| April, 2030 | $5.5106 | $3.8281 | $7.4739 | +3.58% |
| May, 2030 | $5.2902 | $3.0944 | $6.7849 | -0.56% |
| June, 2030 | $3.1312 | $2.9913 | $7.5007 | -41.14% |
| July, 2030 | $1.9413 | $0.187 | $4.1117 | -63.51% |
| August, 2030 | $3.8485 | $0.7185 | $4.6285 | -27.66% |
| September, 2030 | $13.14 | $3.6537 | $14.03 | +147.08% |
| October, 2030 | $12.21 | $9.5358 | $14.14 | +129.43% |
| November, 2030 | $9.6968 | $7.4778 | $15.83 | +82.27% |
| December, 2030 | $0.0731 | $1.4969 | $9.802 | -98.63% |
1.53%
3.38%
Cap:
|
Volume (24h):